These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7969227)

  • 1. Two-stage tuberculin skin testing in an HIV-infected population: a preliminary report.
    Goldstein S; Perlman DC; Salomon N
    Mt Sinai J Med; 1994 Sep; 61(4):337-40. PubMed ID: 7969227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
    Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria.
    Yusuph H; Garbati MA; Gashau W
    Afr J Med Med Sci; 2005 Jun; 34(2):125-8. PubMed ID: 16749335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
    Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S; Fumoux F; Ledru E; Sanou PT; Barro D; Marchal G
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):317-23. PubMed ID: 9559403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.
    Shah SS; McGowan JP; Klein RS; Converse PJ; Blum S; Gourevitch MN
    Med Sci Monit; 2006 Apr; 12(4):MT11-6. PubMed ID: 16572060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
    Klein RS; Gourevitch MN; Teeter R; Schoenbaum EE
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):707-11. PubMed ID: 11495260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of reactivation of tuberculosis in the course of human immunodeficiency virus infection.
    Di Perri G; Micciolo R; Vento S; Cruciani M; Marocco S; Carlotto A; Adami T; Mazzi R; Cazzadori A; Concia E
    Eur J Med; 1993 May; 2(5):264-8. PubMed ID: 7902760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculin test in HIV infection].
    Portu JJ; Pérez JR; Arévalo JM; Aldamiz-Etxebarria M; Agud JM; Ayensa C
    Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):90-5. PubMed ID: 8714155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of purified protein derivative positivity in human immunodeficiency virus infected individuals in Hong Kong.
    Chan KC; Tang HW; Wong K
    Chin Med J (Engl); 2002 Jul; 115(7):1091-2. PubMed ID: 12173600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of positive purified protein derivative test in those infected with human immunodeficiency virus.
    Mohraz M; Ramezani A; Gachkar L; Velayati AA
    Arch Iran Med; 2006 Jul; 9(3):218-21. PubMed ID: 16859054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-step tuberculin skin testing of injection drug users recruited from community-based settings.
    Lifson AR; Grant SM; Lorvick J; Pinto FD; He H; Thompson S; Keudell EG; Stark MJ; Booth RE; Watters JK
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):128-34. PubMed ID: 9441076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. HER Study Group. HIV Epidemiology Research.
    Klein RS; Smith D; Sobel J; Flanigan T; Margolick JB
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):688-92. PubMed ID: 10907773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step tuberculin skin testing in HIV-infected persons in Uganda.
    Hecker MT; Johnson JL; Whalen CC; Nyole S; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1997 Jan; 155(1):81-6. PubMed ID: 9001293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana.
    Kenyon TA; Creek T; Laserson K; Makhoa M; Chimidza N; Mwasekaga M; Tappero J; Lockman S; Moeti T; Binkin N
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):843-50. PubMed ID: 12365569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.